Works matching IS 11732563 AND DT 2018 AND VI 38 AND IP 6


Results: 10
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

    Published in:
    Clinical Drug Investigation, 2018, v. 38, n. 6, p. 553, doi. 10.1007/s40261-018-0629-1
    By:
    • Moiseyenko, Vladimir M.;
    • Moiseyenko, Fedor V.;
    • Yanus, Grigoriy A.;
    • Kuligina, Ekatherina Sh.;
    • Sokolenko, Anna P.;
    • Bizin, Ilya V.;
    • Kudriavtsev, Alexey A.;
    • Aleksakhina, Svetlana N.;
    • Volkov, Nikita M.;
    • Chubenko, Vyacheslav A.;
    • Kozyreva, Kseniya S.;
    • Kramchaninov, Mikhail M.;
    • Zhuravlev, Alexandr S.;
    • Shelekhova, Kseniya V.;
    • Pashkov, Denis V.;
    • Ivantsov, Alexandr O.;
    • Venina, Aigul R.;
    • Sokolova, Tatyana N.;
    • Preobrazhenskaya, Elena V.;
    • Mitiushkina, Natalia V.
    Publication type:
    Article